We are happy to announce the launch of the Orphan Drug Incentives by the European Expert Group.
The below video offers a brief overview of the state of rare diseases in Europe and introduces the Expert Group tasked with examining how to improve the situation.
As Knowledge Partner, Copenhagen Economics are proud to contribute our economics-driven insights and partnership-building approach to this great initiative.
The steering group is composed of EURORDIS, The Voice of Rare Disease Patients in Europe, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) representing several companies focused on finding new therapies for rare disease.
Learn more about the study
For further information, please contact Managing Economist Julia Wahl